Patent: 9,938,331
✉ Email this page to a colleague
Summary for Patent: 9,938,331
Title: | Biologically active proteins having increased in vivo and/or in vitro stability |
Abstract: | The present invention provides unstructured recombinant polymers (URPs) and proteins containing one or more of the URPs. The present invention also provides microproteins, toxins and other related proteinaceous entities, as well as genetic packages displaying these entities. The present invention also provides recombinant polypeptides including vectors encoding the subject proteinaceous entities, as well as host cells comprising the vectors. The subject compositions have a variety of utilities including a range of pharmaceutical applications. |
Inventor(s): | Schellenberger; Volker (Palo Alto, CA), Stemmer; Willem P. (Los Gatos, CA), Wang; Chia-Wei (Santa Clara, CA), Scholle; Michael D. (Mountain View, CA), Gordon; Nathaniel C. (Campbell, CA), Crameri; Andreas (Los Altos Hills, CA), Popkov; Mikhail (San Diego, CA) |
Assignee: | Amunix Operating Inc. (Mountain View, CA) |
Application Number: | 14/970,723 |
Patent Claims: | see list of patent claims |
Details for Patent 9,938,331
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Eli Lilly And Company | HUMATROPE | somatropin | For Injection | 019640 | 06/23/1987 | ⤷ Try a Trial | 2025-09-27 |
Eli Lilly And Company | HUMATROPE | somatropin | For Injection | 019640 | 10/16/1986 | ⤷ Try a Trial | 2025-09-27 |
Eli Lilly And Company | HUMATROPE | somatropin | For Injection | 019640 | 02/04/1999 | ⤷ Try a Trial | 2025-09-27 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |